Northwire Canada EditionFriday, July 10, 2026
Northwire
GGX 0.040 +0.0% S 0.160 +33.3% NNX 0.035 +0.0% ABX 52.12 −0.2% TTS 2.40 −4.0% FCI 0.400 −9.1% GR 0.075 +0.0% AII 23.40 +12.5% TUNG 1.74 +3.0% LGO 1.01 −2.9% EMM 0.080 +0.0% OGN 3.45 +2.1% MSA 6.62 +3.0% SGZ 0.040 −11.1% GRSL 0.305 −4.7% DEX 0.380 −1.3% GGX 0.040 +0.0% S 0.160 +33.3% NNX 0.035 +0.0% ABX 52.12 −0.2% TTS 2.40 −4.0% FCI 0.400 −9.1% GR 0.075 +0.0% AII 23.40 +12.5% TUNG 1.74 +3.0% LGO 1.01 −2.9% EMM 0.080 +0.0% OGN 3.45 +2.1% MSA 6.62 +3.0% SGZ 0.040 −11.1% GRSL 0.305 −4.7% DEX 0.380 −1.3%
Financings Routine +

Realbotix Closes Sale of Domain Name Portfolio for US$2.245

XBOT · Price

Executive Summary

  • Realbotix Corp. closed the sale of its Tokens.com domain portfolio to Bed Bath & Beyond, Inc. for a total consideration of US $2.245 million.
  • The transaction provides immediate cash of US $1.5 million with two deferred payments of US $372,500 each due by 31 Aug 2026 and 31 Jan 2027, strengthening the company’s balance sheet.
  • The sold assets were non‑core digital domain names with no recorded value on the balance sheet, making the proceeds fully additive to equity.

Key Details

  • Total consideration: US $2,245,000.
  • Cash received at closing: US $1,500,000.
  • Deferred payments: US $372,500 due ≤ 31 Aug 2026; US $372,500 due ≤ 31 Jan 2027.
  • Assets sold: Tokens.com domain and related domains – TokensArt.com, TokensGaming.com, TokensTrade.com, TokensTrading.com.
  • Impact on financials: Assets carried no balance‑sheet value; proceeds are fully additive to equity, improving liquidity for scaling AI and robotics operations.
  • CEO comment: “Closing this transaction strengthens our balance sheet at an important moment as we continue scaling the Realbotix platform…”

Notable Quotes

“Closing this transaction strengthens our balance sheet at an important moment as we continue scaling the Realbotix platform and expanding commercial deployments of our humanoid robots,” – Andrew Kiguel, CEO

Read the original news release →

More from Realbotix Corp.